Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial - Greenberg, B; Neaton, J D; Anker, S D (JAMA Cardiol, 2019)